Showing posts with label Causes of Alcoholism. Show all posts
Showing posts with label Causes of Alcoholism. Show all posts

Sunday, October 9, 2016

Older Adults with Long-Term Alcohol Dependence Lose Neurocognitive Abilities

Older Adults with Long Term Alcohol Dependence
Newswise, October 9, 2016— Heavy drinking can lead to neurophysiological and cognitive changes ranging from disrupted sleep to more serious neurotoxic effects. Aging can also contribute to cognitive decline. Several studies on the interaction of current heavy drinking and aging have had varied results.

This study sought to elucidate the relations among age, heavy drinking, and neurocognitive function.

Researchers had 66 participants (35 women, 31 men), recruited from the Brown University Center for AIDS Research, undergo a comprehensive neurocognitive battery of testing.

 Current heavy drinkers (n=21) were classified using National Institute on Alcohol Abuse and Alcoholism criteria and structured clinical interviews and, further, were compared to non-drinkers and moderate drinkers (n=45).

About 53 percent of the total population had a lifetime history of alcohol dependence (AD). Neurocognitive data were grouped according to global cognitive function, attention/executive function, learning, memory, motor function, verbal function, and speed of processing.

Results showed that current heavy drinking in older adults was associated with poorer global cognitive function, learning, memory, and motor function.

Furthermore, a lifetime history of AD was associated with poorer function in the same neurocognitive domains, as well as the attention/executive domain, notwithstanding age.


In summary, although current heavy drinking is associated with significant impairment in a number of neurocognitive domains, it appears that a history of AD is associated with lasting negative consequences for neurocognitive function.

Specific Trauma Experiences Contribute to Women’s Alcohol Use, Differs by Race

Trauma experience contribute to women's alcohol use
 Newswise, October 9, 2016 — Trauma exposure has consistently been reported as a risk factor for alcohol use and related problems. Further, racial differences in alcohol use, alcohol use disorder (AUD), and trauma exposure between European American (EA) and African American (AA) women have been reported previously.

This study sought to identify racial differences in alcohol involvement, and to examine the risk conferred by specific trauma exposures and PTSD for different stages of alcohol involvement in EA and AA women.

Researchers examined data from the Missouri Adolescent Female Twins Study: the mean age of the 3,787 women at time of interview was 24.5 years; 85.4 percent were EA, 14.6 percent AA.

Trauma exposures were defined as sexual abuse (SA), physical abuse (PA), witnessing another person being killed or injured, experiencing an accident, or experiencing a disaster. Trauma exposure was examined as a predictor of alcohol initiation, transition to the first AUD symptom, and transition to an AUD diagnosis – while also considering other substance involvement, parental characteristics, and commonly co-occurring psychiatric disorders.

Results showed that trauma experiences were important contributors to all stages of alcohol involvement in EA women only, with different trauma types conferring risk for each stage of alcohol involvement.

For example, in EA women SA was associated with alcohol initiation prior to the age of 14; PA predicted the transition from initiation to the first AUD symptom; and PA, witnessing injury or death, and SA predicted the transition to an AUD diagnosis.

There were no such findings in AA women. Further, PTSD was not revealed as a significant predictor of AUD in either EA or AA women. The findings suggest that trauma, independent of PTSD, directly contributes to alcohol involvement.


Further, they highlight the importance of considering racial differences when looking at linkages between traumatic experiences and alcohol involvement.

Thursday, September 3, 2015

Alcoholism: A Step Toward a Treatment

Texas A&M team finds neuron responsible for alcoholism

Newswise, September 3, 2015 — Scientists have pinpointed a population of neurons in the brain that influences whether one drink leads to two, which could ultimately lead to a cure for alcoholism and other addictions.

A study, published in the Journal of Neuroscience by researchers at the Texas A&M Health Science Center College of Medicine, finds that alcohol consumption alters the structure and function of neurons in the dorsomedial striatum, a part of the brain known to be important in goal-driven behaviors. 

The findings could be an important step toward creation of a drug to combat alcoholism.

“Alcoholism is a very common disease,” said Jun Wang, M.D., Ph.D., the lead author on the paper and an assistant professor in the Department of Neuroscience and Experimental Therapeutics at the Texas A&M College of Medicine, “but the mechanism is not understood very well.”

Now, Wang and his team have helped come a little closer to that understanding. Using an animal model, the researchers determined that alcohol actually changes the physical structure of medium spiny neurons, the main type of cell in the striatum. 

These neurons can be thought of like a tree, with many branches, and many small protrusions, or spines, coming off of them. They each have one of two types of dopamine receptors, D1 or D2, and so can be thought of as either D1 or D2 neurons. D1 neurons are informally called part of a “go” pathway in the brain, while D2 neurons are in the “no-go” pathway. In other words, when D2 neurons are activated, they discourage action — telling you to wait, to stop, to do nothing.

Although it is well known that the neurotransmitter dopamine is involved in addiction, this study goes further, showing that the dopamine D1 receptor also plays an important role in addiction. 

The team found that periodic consumption of large amounts of alcohol acts on D1 neurons, making them much more excitable, which means that they activate with less stimulation.

“If these neurons are excited, you will want to drink alcohol,” Wang said. 

“You’ll have a craving.” 

That is to say, when neurons with D1 receptors are activated, they compel you to perform an action — reaching for another bottle of tequila, in this case. This then creates a cycle, where drinking causes easier activation, and activation causes more drinking.

These changes in activation of D1 neurons might be related to the physical changes happening at the sub-cellular level in brains that have been exposed to alcohol. They have longer branching and more of the mature, mushroom-shaped spines — the type that stores long-term memories — than their abstaining counterparts.

Conversely, the placebo group, the ones not exposed to alcohol, tended to have more of the immature versions of the mushroom-shaped spines in D1 neurons of their brains. 

The total number of spines didn’t change in the two groups, but the ratio between mature and immature was dramatically different between the alcohol group and the placebo group. This has important implications for memory and learning in drug addiction.

“When you drink alcohol, long-term memory is enhanced, in a way,” Wang said. 

“But this memory process is not useful — in fact, it underlies addiction since it affects the ‘go’ neurons.” 

Because there was no difference in the number of each type of spine in the D2 (no-go) neurons of alcohol-consuming and control models, the researchers realized there was a specific relationship between D1 neurons and alcohol consumption.

“We’re now able to study the brain at the neuron-specific and even spine-specific level,” Wang said.

How do you determine which neuron, which type of neurons or which group of neurons is responsible for a specific disease? That’s what the next part of the study tried to answer.

The alcohol-consuming animal models with the increased mature spines in D1 neurons also showed an increased preference to drink large quantities of alcohol when given the choice.

“Even though they’re small, D1 receptors are essential for alcohol consumption,” Wang said.

Furthermore, and perhaps most excitingly, when those same animal models were given a drug to at least partially block the D1 receptor, they showed much-reduced desire to drink alcohol. 

However, a drug that inhibited the D2 dopamine receptors had no effect. “If we suppress this activity, we’re able to suppress alcohol consumption,” Wang said. 

“This is the major finding. Perhaps in the future, researchers can use these findings to develop a specific treatment targeting these neurons.”

The study, which was co-authored with researchers from the University of California San Francisco, was supported by a grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA).


“My ultimate goal is to understand how the addicted brain works,” Wang said, “and once we do, one day, we’ll be able to suppress the craving for another round of drinks and ultimately, stop the cycle of alcoholism.”

Wednesday, August 19, 2015

New Compounds Could Reduce Alcoholics’ Impulse to Drink

BOSTON, Aug. 19, 2015 — Alcoholism inflicts a heavy physical, emotional and financial toll on individuals and society. Now new discoveries and promising animal studies are offering a glimmer of hope that a new class of drugs could treat the disease without many of the unwanted side effects caused by current therapies.

Researchers are presenting the results of their work today at the 250th National Meeting & Exposition of the American Chemical Society (ACS), the world’s largest scientific society. The meeting features more than 9,000 presentations on a wide range of science topics and is being held here through Thursday.

“Alcoholism is a major problem in the U.S.,” V. V. N. Phani Babu Tiruveedhula says. “Alcohol abuse costs almost $220 billion to the U.S. economy every year. That’s a shocking number. We need a better treatment right now.” Tiruveedhula is a graduate student at the University of Wisconsin, Milwaukee.

The exact causes of alcoholism are not well understood, but the researchers explain that the urge to drink is related to the brain’s pleasure centers. Scientists have found that alcohol triggers the brain to release dopamine, the same neurochemical whose levels increase in response to pleasurable behavior like eating, sex or listening to music.

Some drugs currently available to treat alcoholism are aimed at dopamine. “They dampen out the dopamine system a little bit, so you don’t get so happy when you have an alcoholic beverage,” says James Cook, Ph.D., a chemist at the University of Wisconsin, Milwaukee, who advises Tiruveedhula. But these medications, derived from a class of compounds called opioid antagonists, cause depression in some patients, Cook notes. And they’re addictive themselves, which can lead to drug abuse. Valium is an example of another common drug used to treat alcoholism that is also addictive.

Looking for an alternative, Cook focused on molecules known to cause some of the same results as Valium and the opioid antagonists without the unwanted side effects. For almost two decades, Cook collaborated with the late Harry June, Ph.D., a psychopharmacologist at Howard University. They conducted laboratory tests to understand the effects of these new compounds and to discover which ones work best.

Now, Tiruveedhula has made several of these promising beta-carboline compounds that could represent the future of alcoholism treatment. Tiruveedhula simplified their manufacture from eight steps to just two, while increasing the yield tenfold and eliminating unwanted byproducts. Cook says these potential medications could be taken orally.

In tests using rats bred to crave alcohol, the scientists found that administering these compounds drastically diminished the rats’ drinking. What’s more, they observed very few of the side effects common to alcoholism treatment drugs, such as depression and losing the ability to experience pleasure. The drugs appeared to reduce anxiety in “alcoholic” rats, but not in control rats. Because this is different from what is seen with current drugs, the researchers think the result hints that the new compounds work much differently than opioid antagonists. As such, the beta-carbolines may also be less addictive.

“What excites me is the compounds are orally active, and they don’t cause depression like some drugs do,” says Cook.

The group is continuing to test the compounds in additional animal studies. Cook has patented several of the most promising compounds, and he is starting to explore possible partnerships with drug makers that could lead to medications.

If everything works out, Cook says, a drug could be ready for the market in five to six years.

The researchers acknowledge funding from the National Institute on Alcohol Abuse and Alcoholism.

The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 158,000 members, ACS is the world’s largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.

Follow us on Twitter | Facebook

Saturday, August 15, 2015

Study Finds Lack of Ultimate Meaning in Life Associated with Alcohol Abuse, Drug Addiction and Other Mental Health Problems

Newswise, August 15, 2015 — One of the most commonly used treatment models in addiction is the 12-step model developed in the 1930s and rooted in spirituality. Yet, surprisingly, there is no clear understanding about how to nurture spirituality among people struggling with addictions.

In a unique study titled “Attachment Style, Spirituality, and Depressive
Symptoms Among Individuals in Substance Abuse Treatment,” published in the Journal of Social Service Research, Gail Horton, Ph.D., associate professor; Naelys Luna, Ph.D., associate professor, School of Social Work in the College for Design and Social Inquiry at Florida Atlantic University, and Tammy Malloy, LCSW, chief clinical officer, Behavioral Health of the Palm Beaches (BHOPB), demonstrate that the lack of ultimate meaning in life, an important dimension of spirituality, is associated with alcohol abuse and drug addiction, as well as other mental health problems including anxiety and depression. 

Although adult attachment styles and spirituality have been shown to be protective factors against depressive symptoms among individuals in treatment for substance use disorders, no studies to date have examined how these two factors together are related to depressive symptoms in this population.
Horton, Luna and Malloy looked at how adult attachment styles (secure vs. insecure) and two distinct spirituality dimensions (existential purpose/meaning in life and religious well-being or the perceived relationship with God) are associated with depressive symptoms.
Working in collaboration with BHOPB, a substance abuse treatment center in Palm Beach County, Horton, Luna and Malloy developed a research model that looks at how creativity, service and solitude can be used in addiction treatment to foster purpose and meaning in life. They found that encouraging people’s creative talents (painting, writing), giving them opportunities to serve others, and helping them to connect to core values and their true self through prayer and meditation helped them to discover ultimate purpose and meaning as part of their recovery process.
A key finding of their research shows that having an insecure attachment style appears to be a risk factor for developing depressive symptoms. Another significant finding shows that the existential-purpose and meaning-in-life dimension of spirituality seems to be the most important factor related to depressive symptoms in this sample population.
Horton and Luna note that although their research results suggest that practitioners could consider focusing on promoting improved interpersonal relationships for individuals with insecure attachment styles, they may want to place fostering purpose and meaning in life as a higher priority for treatment planning.
“Programs such as the 12-step model might want to take into consideration the relative importance of the two spiritual dimensions and put into place programmatic support for the development of purpose and meaning in life rather than only stressing the perceived closeness to God,” said Malloy.

Addiction is one of the most damaging health problems in the U.S. today and the World Health Organization (WHO) reports that by 2020, mental health and substance use disorders will be a major cause of disability worldwide surpassing physical illness. 

In 2009, an estimated 23.5 million Americans ages 12 and older required addiction treatment. The societal cost of substance abuse problems is approximately $511 billion.

“The cutting-edge research conducted by Drs. Horton and Luna and Ms. Malloy is extremely important because it sheds light on different ways to help individuals in treatment addiction,” said John R. Graham, Ph.D., professor and director of FAU’s School of Social Work. 

“This in turn not only helps the clients receiving treatment, but also improves how addiction professionals do their work - contributing to the health and well-being of the broader community.”

-FAU-
Florida Atlantic University
Florida Atlantic University, established in 1961, officially opened its doors in 1964 as the fifth public university in Florida. Today, the University, with an annual economic impact of $6.3 billion, serves more than 30,000 undergraduate and graduate students at sites throughout its six-county service region in southeast Florida. FAU’s world-class teaching and research faculty serves students through 10 colleges: the Dorothy F. Schmidt College of Arts and Letters, the College of Business, the College for Design and Social Inquiry, the College of Education, the College of Engineering and Computer Science, the Graduate College, the Harriet L. Wilkes Honors College, the Charles E. Schmidt College of Medicine, the Christine E. Lynn College of Nursing and the Charles E. Schmidt College of Science. FAU is ranked as a High Research Activity institution by the Carnegie Foundation for the Advancement of Teaching. The University is placing special focus on the rapid development of critical areas that form the basis of its strategic plan: Healthy aging, biotech, coastal and marine issues, neuroscience, regenerative medicine, informatics, lifespan and the environment. These areas provide opportunities for faculty and students to build upon FAU’s existing strengths in research and scholarship. For more information, visit www.fau.edu.
Behavioral Health of the Palm Beaches
Behavioral Health of the Palm Beaches (BHOPB) is a leading addiction care organization located in South Florida offering patients comprehensive treatment for chemical dependency and mental illness. Comprised of four specialty facilities (the Recovery Center for Men, the Recovery Center for Women, Seaside Palm Beach, and Mental Health Rehab of the Palm Beaches). BHOPB provides patients with individualized care programs that span the entire treatment process, from intervention services to medically supervised detoxification to customized inpatient rehab to aftercare. Since its inception in 1997, BHOPB has grown to be one of the top addiction care organizations in the country through an ever-expanding spectrum of therapies, world-renowned research department and industry-leading clinical staff. For more information visit